Salem Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $508K | Hold |
7,233
| – | – | 0.4% | 40 |
|
|
2022
Q2 | $580K | Sell |
7,233
-2,284
| -24% | -$179K | 0.42% | 39 |
|
|
2022
Q1 | $722K | Buy |
9,517
+267
| +3% | +$21.1K | 0.4% | 44 |
|
|
2021
Q4 | $789K | Sell |
9,250
-600
| -6% | -$46.9K | 0.41% | 47 |
|
|
2021
Q3 | $744K | Sell |
9,850
-2,598
| -21% | -$206K | 0.41% | 46 |
|
|
2021
Q2 | $1.01M | Sell |
12,448
-2
| -0% | -$164 | 0.56% | 39 |
|
|
2021
Q1 | $981K | Hold |
12,450
| – | – | 0.58% | 38 |
|
|
2020
Q4 | $1.06M | Hold |
12,450
| – | – | 0.68% | 36 |
|
|
2020
Q3 | $961K | Hold |
12,450
| – | – | 0.7% | 34 |
|
|
2020
Q2 | $912K | Hold |
12,450
| – | – | 0.65% | 34 |
|
|
2020
Q1 | $826K | Hold |
12,450
| – | – | 0.68% | 34 |
|
|
2019
Q4 | $857K | Hold |
12,450
| – | – | 0.47% | 38 |
|
|
2019
Q3 | $915K | Hold |
12,450
| – | – | 0.52% | 39 |
|
|
2019
Q2 | $892K | Hold |
12,450
| – | – | 0.5% | 42 |
|
|
2019
Q1 | $853K | Sell |
12,450
-300
| -2% | -$19.4K | 0.46% | 40 |
|
|
2018
Q4 | $759K | Hold |
12,750
| – | – | 0.48% | 41 |
|
|
2018
Q3 | $854K | Sell |
12,750
-300
| -2% | -$20K | 0.46% | 41 |
|
|
2018
Q2 | $846K | Hold |
13,050
| – | – | 0.45% | 41 |
|
|
2018
Q1 | $935K | Sell |
13,050
-1,300
| -9% | -$93.6K | 0.51% | 40 |
|
|
2017
Q4 | $1.08M | Hold |
14,350
| – | – | 0.55% | 38 |
|
|
2017
Q3 | $1.04M | Hold |
14,350
| – | – | 0.54% | 40 |
|
|
2017
Q2 | $1.06M | Hold |
14,350
| – | – | 0.59% | 38 |
|
|
2017
Q1 | $1.05M | Sell |
14,350
-600
| -4% | -$42K | 0.58% | 41 |
|
|
2016
Q4 | $978K | Hold |
14,950
| – | – | 0.54% | 41 |
|
|
2016
Q3 | $1.11M | Hold |
14,950
| – | – | 0.61% | 40 |
|
|
2016
Q2 | $1.09M | Sell |
14,950
-200
| -1% | -$14.2K | 0.63% | 40 |
|
|
2016
Q1 | $1.07M | Hold |
15,150
| – | – | 0.6% | 40 |
|
|
2015
Q4 | $1.01M | Hold |
15,150
| – | – | 0.57% | 41 |
|
|
2015
Q3 | $961K | Hold |
15,150
| – | – | 0.56% | 41 |
|
|
2015
Q2 | $991K | Hold |
15,150
| – | – | 0.51% | 37 |
|
|
2015
Q1 | $1.05M | Hold |
15,150
| – | – | 0.53% | 37 |
|
|
2014
Q4 | $1.05M | Hold |
15,150
| – | – | 0.5% | 41 |
|
|
2014
Q3 | $988K | Sell |
15,150
-1,406
| -8% | -$92.7K | 0.46% | 40 |
|
|
2014
Q2 | $1.13M | Hold |
16,556
| – | – | 0.5% | 42 |
|
|
2014
Q1 | $1.07M | Hold |
16,556
| – | – | 0.47% | 42 |
|
|
2013
Q4 | $1.08M | Hold |
16,556
| – | – | 0.47% | 43 |
|
|
2013
Q3 | $982K | Hold |
16,556
| – | – | 0.45% | 46 |
|
|
2013
Q2 | $948K | Buy |
+16,556
| New | +$983K | 0.45% | 45 |
|
Other funds holding CL
TP
Salem Capital Management's CL Position: Q3 2022 in Review
Salem Capital Management held its Colgate-Palmolive (CL) position steady in Q3 2022 at 7,233 shares worth $508K. The position accounts for 0.4% of the portfolio, ranked #40.
Salem Capital Management first reported a position in CL in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.13M in Q2 2014. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.
- Salem Capital Management held 7,233 shares of Colgate-Palmolive worth $508K as of Q3 2022.
- Salem Capital Management left its Colgate-Palmolive share count unchanged in Q3 2022.
- Colgate-Palmolive made up 0.4% of Salem Capital Management's portfolio in Q3 2022, its #40 holding.
- Salem Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 38 quarters since.
- Salem Capital Management's Colgate-Palmolive position peaked at $1.13M in Q2 2014.
- 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.
Based on Salem Capital Management's 13F filing for Q3 2022, filed 29 Nov 2022.